novo nordisk semaglutide wins EU approval for Wegovy weight-loss pill Novo Nordisk withdraws FDA application
Description
It uses the Gridfinity system
95% CI, 1.062.20) compared with the placebo
average islet size ( T )
To prevent injuries and scar tissue, rotate injection sites each week
These key findings demonstrate the benefit of imaging in clinical trials and especially the high potential of the MRI-PDFF assessment as a key endpoint for studies
